Close Menu

McKesson

McKesson will be the exclusive distributor of the QiaStat-Dx system in US hospitals with fewer than 200 beds and non-exclusive distributor for future expansion into retail pharmacy clinics.

Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.

The coding requirements will be a particularly complicated aspect of implementing the new law which aims to move diagnostic pricing to a market-based system.

NEW YORK (GenomeWeb News) – Atossa Genetics today said that McKesson Medical-Surgical will distribute and sell the firm's MASCT device and patient collection kits.

Theranostics Health this week announced the June launch of its first commercial test, a 14-protein assay for profiling activation of the HER signaling network.

In a move that surprised many stakeholders in the molecular diagnostics industry, the American Medical Association and healthcare information technology firm McKesson last week announced that they are working together to harmonize their respective coding systems for molecular tes

NEW YORK (GenomeWeb News) – The American Medical Association and McKesson announced a licensing deal today to create a reference product for identifying and tracking molecular diagnostic tests.

This article has been updated to include comments from Palmetto Medical Director Elaine Jeter. Originally published Jan. 26.

This article has been updated to clarify information about NIH's Genetic Testing Registry.

Pages

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational biologist James Taylor has died, according to Johns Hopkins University.

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.